| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.087 | 0.07 |